CorMedix (CRMD) Receivables: 2013-2025
Historic Receivables for CorMedix (CRMD) over the last 9 years, with Sep 2025 value amounting to $162.6 million.
- CorMedix's Receivables rose 835.01% to $162.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $311.8 million, marking a year-over-year increase of 1618.38%. This contributed to the annual value of $51.7 million for FY2024, which is N/A change from last year.
- According to the latest figures from Q3 2025, CorMedix's Receivables is $162.6 million, which was up 278.86% from $42.9 million recorded in Q2 2025.
- CorMedix's 5-year Receivables high stood at $162.6 million for Q3 2025, and its period low was $2,975 during Q1 2022.
- Moreover, its 2-year median value for Receivables was $47.3 million (2024), whereas its average is $55.0 million.
- Per our database at Business Quant, CorMedix's Receivables slumped by 93.18% in 2022 and then skyrocketed by 5,975.24% in 2025.
- CorMedix's Receivables (Quarterly) stood at $45,368 in 2021, then tumbled by 93.18% to $2,975 in 2022, then reached $51.7 million in 2024, then skyrocketed by 835.01% to $162.6 million in 2025.
- Its Receivables stands at $162.6 million for Q3 2025, versus $42.9 million for Q2 2025 and $54.6 million for Q1 2025.